FBT-A05

DB33758Investigational

FBT-A05: Overview.

Mechanism: Pharmacologically active on B-lymphocyte antigen CD20 and T-cell surface glycoprotein CD3
Curator reviewed
Code names: FBT-A05

Resolves to

Compound

Targets

What you can answer from here — as of August 28, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with FBT-A05, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.